Stéphanie Forté: Gene Therapy in Sickle Cell Disease from Molecular Advances to Clinical Care
Stéphanie Forté, Principal Researcher at the Innovation Hub at the CHUM Research Center (CRCHUM), shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Very excited to share our new review on gene therapies in sickle cell disease, published in Cells:
The Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care
Advances in gene therapy are ushering in a new era of hope for people living with sickle cell disease.
Our hope now is that these innovations become more equitably accessible worldwide.
The RED Network (Erythrocytes and Sickle Cell Network) continues to pursue this goal by strengthening international collaborations, patient registries, andclinical research in order to accelerate meaningful global progress for patients.”
Title: The Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care
Authors: Magalie Tardif, Manon Saby, Stéphanie Forté, Thomas Pincez
Stay updated on all scientific advances with Hemostasis Today.
-
May 21, 2026, 16:21Ifeanyichukwu Ifechidere: Rebalanced Haemostasis in Liver Disease
-
May 21, 2026, 15:22Divyaswathi Citla Sridhar: Addressing the Gaps in Inherited Platelet Function Disorders
-
May 21, 2026, 14:35Wolfgang Miesbach: From genes to mechanisms – An Outstanding Update on Inherited Platelet Disorders
-
May 21, 2026, 14:04Bastu Odoka։ The World of Transfusion Medicine Keeps Evolving
-
May 21, 2026, 13:53A New Story of Hope for Children With ITP – ITP Support Association
-
May 21, 2026, 13:40Sonal Sonu: Less Than 50 People in the World Have Golden Blood
-
May 21, 2026, 13:33Danny Hsu: Honoured to Speak at the International Society of Hematology Congress in Bangkok
-
May 21, 2026, 13:19Jürgen Naudts: What If the Best Transfusion Insights Don’t Come From Guidelines… but From Your Neighbour?
-
May 21, 2026, 13:08Mosa Safi: Updated TXA Recommendations in Tactical Combat Casualty Care